Loading...
InhaleRx Limited
IRX.AX•ASX
Healthcare
Medical - Devices
A$0.04
A$-0.01(-11.90%)
InhaleRx Limited (IRX.AX) Financial Performance & Income Statement Overview
Explore the financials of InhaleRx Limited (IRX.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Revenue Growth
-72.17%
↓ 72.17%
Operating Income Growth
4.28%
↑ 4.28%
Net Income Growth
11.58%
↑ 11.58%
Operating Cash Flow Growth
81.20%
↑ 81.20%
Operating Margin
-396.04%
↓ 396.04%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-380.81%
↓ 380.81%
ROE
1709.33%
↑ 1709.33%
ROIC
2085.21%
↑ 2085.21%
InhaleRx Limited (IRX.AX) Income Statement & Financial Overview
Explore comprehensive income reports for InhaleRx Limited IRX.AX, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $106851.00 | $106851.00 | $60698.00 | $60698.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $106851.00 | $106851.00 | $60698.00 | $60698.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $217867.00 | $217867.00 | $93182.00 | $93182.00 |
| SG&A Expenses | $234299.00 | $234299.00 | $285767.00 | $285767.00 |
| Operating Expenses | $452166.00 | $452166.00 | $378949.00 | $378949.00 |
| Total Costs & Expenses | $452166.00 | $452166.00 | $378949.00 | $378949.00 |
| Interest Income | $0.00 | $0.00 | $3636.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $55368.00 | $0.00 |
| Depreciation & Amortization | $330094.00 | $330094.00 | $342922.00 | $342922.00 |
| EBITDA | $0.00 | $0.00 | -$460681.00 | $24671.00 |
| EBITDA Ratio | $0.00 | $0.00 | -$7.59 | $0.41 |
| Operating Income | -$345315.00 | -$345315.00 | -$318251.00 | -$318251.00 |
| Operating Income Ratio | -$3.23 | -$3.23 | -$5.24 | -$5.24 |
| Other Income/Expenses (Net) | $76059.00 | $76059.00 | -$50537.00 | -$50537.00 |
| Income Before Tax | -$269256.00 | -$269256.00 | -$368788.00 | -$368788.00 |
| Income Before Tax Ratio | -$2.52 | -$2.52 | -$6.08 | -$6.08 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$269256.00 | -$269256.00 | -$368788.00 | -$368788.00 |
| Net Income Ratio | -$2.52 | -$2.52 | -$6.08 | -$6.08 |
| EPS | -$0.001 | -$0.001 | -$0.002 | -$0.002 |
| Diluted EPS | -$0.001 | -$0.001 | -$0.002 | -$0.002 |
| Weighted Avg Shares Outstanding | $237.23M | $237.23M | $189.77M | $189.12M |
| Weighted Avg Shares Outstanding (Diluted) | $237.13M | $237.13M | $189.77M | $189.77M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan